The STIKO recommends vaccination against COVID-19 with one of the two approved mRNA-Vaccines (Comirnaty from BioNTech / Pfizer, COVID-19-Vaccine from Moderna) or one of the two approved vector-based vaccines (Vaxzevria from AstraZeneca, COVID-19 Vaccine Janssen from Janssen-Cilag International). As the Epidemiological Bulletin 23/2021 explains, the STIKO recommends vaccination with the mRNA vaccine Comirnaty (BioNTech / Pfizer) in children and adolescents with previous illnesses due to an assumed increased risk of a severe course of COVID-19 disease. The use of Comirnaty in children and adolescents aged 12-17 years without previous illnesses is currently not generally recommended, but is possible after medical advice and with individual wishes and risk acceptance.
- Recommendation
- Europe
- Germany
- adolescents
- COVID-19
